Currently out of the existing stock ratings of Samuel Brodovsky, 24 are a BUY (68.57%), 11 are a HOLD (31.43%).

Samuel Brodovsky

Work Performance Price Targets & Ratings Chart

Analyst Samuel Brodovsky, has had 85% of price targets met with an average potential upside of 19.53%, reached in 388 days on average. Previously, Samuel Brodovsky worked at TRUIST, PIPER SANDLER.

Samuel Brodovsky has documented 69 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on VCEL, Vericel Corp Ord at 10-Nov-2024.

Wall Street Analyst Samuel Brodovsky

Analyst best performing recommendations are on VCEL (VERICEL CORP ORD).
The best stock recommendation documented was for VCEL (VERICEL CORP ORD) on 11/9/2022. The price target of $22 was fulfilled within 1 day with a profit of $4.35 (24.65%), with a performance score of 246.46.

Average potential price target upside

KIDS Orthopediatrics Corp VCEL Vericel Corp Ord GKOS Glaukos Corp SIBN Si-Bone GMED Globus Medical IART Integra LifeSciences Holdings NUVA NuVasive

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Nov-2017

$45

$13.26 (41.78%)

$30

2 days ago
(18-Nov-2026)

Buy Since 05-Nov-2017

$40

$8.26 (26.02%)

$30

3 days ago
(17-Nov-2026)

Buy Since 26-Jan-2026

$28

$-3.74 (-11.78%)

$23

24 days ago
(28-Oct-2026)

1/2 (50%)

$-2.8 (-9.09%)

195

Buy Since 05-Nov-2017

$27

$-4.74 (-14.93%)

$20

24 days ago
(28-Oct-2026)

12/17 (70.59%)

$-3.8 (-12.34%)

200

Buy Since 19-Jun-2019

$35

$3.26 (10.27%)

$30

3 months 16 days ago
(05-Aug-2026)

11/27 (40.74%)

$12.69 (56.88%)

180

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?